SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-08-002345
Filing Date
2008-05-16
Accepted
2008-05-15 19:25:05
Documents
10
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER form6k.htm 6-K 6262
2 NEWS RELEASE DATED MARCH 31, 2008 exhibit99-1.htm EX-99.1 9825
3 MANAGEMENT DISCUSSION AND ANALYSIS FOR THE PERIOD ENDED MARCH 31, 2008 exhibit99-2.htm EX-99.2 79161
4 INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDED MARCH 31, 2008 exhibit99-3.htm EX-99.3 234749
5 FORM 52-109F2 - CERTIFICATE OF INTERIM FILINGS - CEO exhibit99-4.htm EX-99.4 4953
6 FORM 52-109F2 - CERTIFICATE OF INTERIM FILINGS - CFO exhibit99-5.htm EX-99.5 5007
7 logo.gif GRAPHIC 7568
8 newsrelease_header.jpg GRAPHIC 18866
9 exhibit99-3x2x1.jpg GRAPHIC 1671
10 exhibit99-3x2x2.jpg GRAPHIC 1440
  Complete submission text file 0001062993-08-002345.txt   382555
Mailing Address 8900 GLENLYON PARKWAY SUITE 100 BURNABY A1 V5J 5J8
Business Address 8900 GLENLYON PARKWAY SUITE 100 BURNABY A1 V5J 5J8 6046814101
RESPONSE BIOMEDICAL CORP (Filer) CIK: 0000806888 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-50571 | Film No.: 08840036
SIC: 8734 Services-Testing Laboratories
Assistant Director 9